University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

Funding Opportunities

[ LSOs | Intramural Awards | Foundations/Other | NIH Announcements ]

Limited Submission Opportunities

(Applications through LSO office)

Intramural Funding Opportunities

  • N/A

Foundations/Other Sources

  • Deadline: Ongoing
    Brander Beacons Cancer Research Foundation

    Our mission is to invest in breakthrough research, scientists, and programs to prevent, better treat, and cure breast and prostate cancer. We are opening a period for submitting proposals and plan to evaluate and award grants throughout 2019. Our grants are typically $5,000 - $25,000 but open to discussion based on opportunities.
  • Deadline: July 1
    Innovation Award from Damon Runyon Cancer Research Foundation

    The Damon Runyon-Rachleff Innovation Award provides support for the next generation of exceptionally creative thinkers with "high-risk/high-reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis and treatment of cancer. This award is specifically designed to provide funding for extraordinary early career researchers who have an innovative, new idea but lack sufficient preliminary data to obtain traditional funding. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field.
  • LOI Deadline: July 9
    NCCN/AstraZeneca Quality of Care & Clinical Care Pathways in Unresectable Stage III / Stage IV Non-Small Cell Lung Cancer Request for Proposals (RFP)
    The intent of this RFP is to encourage NCCN Member Institutions to submit LOIs describing concepts for developing, implementing, and evaluating healthcare provider performance and/or healthcare quality improvement initiatives to enhance patient care and outcomes in unresectable stage III NSCLC patients and stage IV NSCLC patients receiving first line therapy. 
  • LOI Deadline: July 22
    NCCN/AstraZeneca Quality of Care Evaluations in Advanced Ovarian Cancer Request for Proposals (RFP)
    The intent of this RFP is to encourage investigators at NCCN Member Institutions to submit letters of intent (LOIs) describing concepts for developing, implementing, and evaluating initiatives to improve patient outcomes in Stages III/IV and recurrent EOC. Studies aimed at enhancing the quality of multiple aspects of patient interaction and management throughout the clinical care continuum will be eligible. Special consideration will be given to “outside the box” innovative projects, with a special focus on optimizing testing and effectiveness of new healthcare-related paradigms.
  • Deadline: August 2
    The Gordon and Betty Moore Diagnostic Excellence Initiative Funding

    The foundation is soliciting novel ideas and approaches for developing new clinical measures to improve diagnosis, specifically targeting three major categories of disease: acute vascular events (such as stroke and myocardial infarction), infections (such as sepsis and pneumonia) and cancer (such as lung and colorectal cancer).
  • Deadline: August 9
    Beckman Young Investigators

    The Beckman Young Investigator (BYI) Program provides research support to the most promising young faculty members in the early stages of their academic careers in the chemical and life sciences, particularly to foster the invention of methods, instruments and materials that will open up new avenues of research in science.
  • Deadline: August 28
    NCCN/Pfizer Enhancing Academic-Community-Patient Partnerships in Metastatic Breast Cancer Care RFP

    The intent of this RFP is to encourage investigators at NCCN Member Institutions to submit proposals describing concepts for developing best practices and collaborative oncology care models between academic centers and referring community providers.  The overarching goal is to leverage the expertise and resources of NCCN-designated cancer centers to improve quality and outcomes across the continuum of care for all MBC patients.

NIH Announcements

To view all NCI funding opportunities, search here

To view Cancer Moonshot funding opportunities, search here.